Legal & General Group’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,598
| Closed | -$5.18K | – | 3555 |
|
|
2025
Q1 | $5.18K | Hold |
1,598
| – | – | ﹤0.01% | 3275 |
|
|
2024
Q4 | $6.31K | Hold |
1,598
| – | – | ﹤0.01% | 3320 |
|
|
2024
Q3 | $12.4K | Hold |
1,598
| – | – | ﹤0.01% | 3231 |
|
|
2024
Q2 | $8.14K | Buy |
+1,598
| New | +$8.14K | ﹤0.01% | 3334 |
|
|
2022
Q3 | – | Sell |
-1,257
| Closed | -$7K | – | 3492 |
|
|
2022
Q2 | $7K | Sell |
1,257
-3,771
| -75% | -$21K | ﹤0.01% | 3422 |
|
|
2022
Q1 | $43K | Hold |
5,028
| – | – | ﹤0.01% | 3025 |
|
|
2021
Q4 | $56K | Hold |
5,028
| – | – | ﹤0.01% | 3011 |
|
|
2021
Q3 | $65K | Buy |
5,028
+3,623
| +258% | +$46.8K | ﹤0.01% | 2921 |
|
|
2021
Q2 | $23K | Sell |
1,405
-949
| -40% | -$15.5K | ﹤0.01% | 3251 |
|
|
2021
Q1 | $41K | Buy |
2,354
+1,097
| +87% | +$19.1K | ﹤0.01% | 2885 |
|
|
2020
Q4 | $20K | Hold |
1,257
| – | – | ﹤0.01% | 3096 |
|
|
2020
Q3 | $24K | Sell |
1,257
-628
| -33% | -$12K | ﹤0.01% | 2928 |
|
|
2020
Q2 | $26K | Sell |
1,885
-220
| -10% | -$3.03K | ﹤0.01% | 2957 |
|
|
2020
Q1 | $22K | Sell |
2,105
-1,891
| -47% | -$19.8K | ﹤0.01% | 2884 |
|
|
2019
Q4 | $75K | Buy |
3,996
+380
| +11% | +$7.13K | ﹤0.01% | 2686 |
|
|
2019
Q3 | $38K | Buy |
3,616
+834
| +30% | +$8.76K | ﹤0.01% | 2859 |
|
|
2019
Q2 | $21K | Buy |
+2,782
| New | +$21K | ﹤0.01% | 3181 |
|
|
2018
Q2 | – | Sell |
-2,821
| Closed | -$15K | – | 3389 |
|
|
2018
Q1 | $15K | Sell |
2,821
-2,702
| -49% | -$14.4K | ﹤0.01% | 3165 |
|
|
2017
Q4 | $22K | Hold |
5,523
| – | – | ﹤0.01% | 3132 |
|
|
2017
Q3 | $24K | Hold |
5,523
| – | – | ﹤0.01% | 3123 |
|
|
2017
Q2 | $26K | Hold |
5,523
| – | – | ﹤0.01% | 3086 |
|
|
2017
Q1 | $93K | Hold |
5,523
| – | – | ﹤0.01% | 2588 |
|
|
2016
Q4 | $56K | Buy |
5,523
+2,548
| +86% | +$25.8K | ﹤0.01% | 2856 |
|
|
2016
Q3 | $38K | Hold |
2,975
| – | – | ﹤0.01% | 2648 |
|
|
2016
Q2 | $60K | Buy |
+2,975
| New | +$60K | ﹤0.01% | 2381 |
|